Amphastar Pharmaceuticals AMPH Enterprise value

Enterprise value at other companies

PfizerPFE

$222.4B+9.2%

Halozyme TherapeuticsHALO

$11.3B+39.2%

Emergent BiosolutionsEBS

$879.68M+13.9%

ViatrisVTRS

$31.23B+26.4%

Aquestive Therapeutics, Inc.AQST

$460.11M+65.5%

Opko HealthOPK

$1.18B+9.8%

FAQ

What is Amphastar Pharmaceuticals's enterprise value?

Amphastar Pharmaceuticals (AMPH) reported enterprise value of $1.35B in Q2 2026.

How has Amphastar Pharmaceuticals's enterprise value changed year-over-year?

Amphastar Pharmaceuticals's enterprise value decreased by 16.7% year-over-year, from $1.63B to $1.35B.

What is the long-term trend for Amphastar Pharmaceuticals's enterprise value?

Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's enterprise value has grown at a 12.9% compound annual growth rate (CAGR), from $937.4M to $1.72B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.